# Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults

> **NCT01267058** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 550 (actual)

## Conditions studied

- Diphtheria
- Pertussis
- Tetanus

## Interventions

- **BIOLOGICAL:** GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine
- **BIOLOGICAL:** GSK Biologicals' acellular pertussis vaccine
- **BIOLOGICAL:** Commonwealth Serum Laboratories' combined diphtheria and tetanus vaccine

## Key facts

- **NCT ID:** NCT01267058
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-09
- **Primary completion:** 1998-02
- **Final completion:** 1998-02
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2010-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01267058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01267058, "Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01267058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*